ReNetx Bio
  • Vision & Leadership
    • Our Team
    • Board of Directors
    • Advisory Board
    • Investors & Partners
  • Science & Pipeline
    • Mechanism
    • Pipeline
    • Publications
  • Clinical Trial
    • Clinical Trial
    • SCI Advisory Committee
    • Commitment to SCI
    • Expanded Access Policy
  • News
  • Contact
    • Contact
    • FCOI Policy
  • Vision & Leadership
    • Our Team
    • Board of Directors
    • Advisory Board
    • Investors & Partners
  • Science & Pipeline
    • Mechanism
    • Pipeline
    • Publications
  • Clinical Trial
    • Clinical Trial
    • SCI Advisory Committee
    • Commitment to SCI
    • Expanded Access Policy
  • News
  • Contact
    • Contact
    • FCOI Policy
Due to the COVID-19 ongoing public health risks and burden on clinical trial sites, we are closely monitoring the situation. We continue to collect contact information for those interested in trial participation.​
Picture
​For more information about the RESET Study, including contact information for sites that are actively recruiting, please visit
ClinicalTrials.gov NCT03989440
To learn more about clinical trials and whether participation might be right for you or a loved one, please speak with your doctor.

Sign up here for our periodic company updates

CONTACT    |    © 2021 ReNetX Bio, Inc. All Rights Reserved.